Department of Translational Medical Science, University of Campania Luigi Vanvitelli, Naples, Italy.
CEINGE-Biotecnologie Avanzate-Franco Salvatore, Naples, Italy.
Lung. 2023 Oct;201(5):455-466. doi: 10.1007/s00408-023-00645-3. Epub 2023 Sep 26.
Once thought to be a sterile environment, it is now established that lungs are populated by various microorganisms that participate in maintaining lung function and play an important role in shaping lung immune surveillance. Although our comprehension of the molecular and metabolic interactions between microbes and lung cells is still in its infancy, any event causing a persistent qualitative or quantitative variation in the composition of lung microbiome, termed "dysbiosis", has been virtually associated with many respiratory diseases. A deep understanding of the composition and function of the "healthy" lung microbiota and how dysbiosis can cause or participate in disease progression will be pivotal in finding specific therapies aimed at preventing diseases and restoring lung function. Here, we review lung microbiome dysbiosis in different lung pathologies and the mechanisms by which these bacteria can cause or contribute to the severity of the disease. Furthermore, we describe how different respiratory disorders can be caused by the same pathogen, and that the real pathogenetic mechanism is not only dependent by the presence and amount of the main pathogen but can be shaped by the interaction it can build with other bacteria, fungi, and viruses present in the lung. Understanding the nature of this bacteria crosstalk could further our understanding of each respiratory disease leading to the development of new therapeutic strategies.
曾经被认为是无菌的环境,现在已经确定肺部存在着各种微生物,这些微生物参与维持肺功能,并在塑造肺部免疫监视方面发挥着重要作用。尽管我们对微生物和肺细胞之间的分子和代谢相互作用的理解还处于起步阶段,但任何导致肺部微生物组组成发生持续的定性或定量变化的事件,即“失调”,几乎都与许多呼吸道疾病有关。深入了解“健康”肺部微生物组的组成和功能,以及失调如何导致或参与疾病进展,对于寻找旨在预防疾病和恢复肺功能的特定治疗方法至关重要。在这里,我们综述了不同肺部病理中的肺部微生物组失调以及这些细菌如何导致或加重疾病的机制。此外,我们还描述了不同的呼吸障碍如何由同一病原体引起,并且真正的发病机制不仅取决于主要病原体的存在和数量,还可以通过它与肺部其他细菌、真菌和病毒的相互作用来塑造。了解这种细菌相互作用的性质可以进一步加深我们对每种呼吸道疾病的理解,从而为开发新的治疗策略提供依据。
Semin Respir Crit Care Med. 2018-3-26
Microb Pathog. 2023-5
Eur Arch Otorhinolaryngol. 2017-2
J Bras Pneumol. 2018
Immunobiology. 2018
Prog Mol Biol Transl Sci. 2022
Front Cell Infect Microbiol. 2025-7-28
Lung. 2024-2
Int J Chron Obstruct Pulmon Dis. 2022
Nat Rev Microbiol. 2023-4
Am J Respir Crit Care Med. 2023-4-1
Life (Basel). 2022-7-28
Cancers (Basel). 2022-6-26